The Race for the Next Ozempic

The chapter explores the competitive landscape among pharmaceutical companies in developing innovative obesity drugs, particularly focusing on GLP-1 receptor agonists. It delves into the potential of these drugs in managing weight loss, highlighting various companies' efforts, effectiveness, and necessary advancements in the obesity treatment market.